Literature DB >> 18085545

AP/MALDI-MS complete characterization of the proteolytic fragments produced by the interaction of insulin degrading enzyme with bovine insulin.

Giuseppe Grasso1, Enrico Rizzarelli, Giuseppe Spoto.   

Abstract

The prominent role that insulin degrading enzyme (IDE) has in the clearance of insulin as well as of other molecules such as amyloid-beta has recently drawn much interest in the scientific community toward this protease. In order to give an insight into the manner of interaction of IDE with its substrates, several papers have focused on the structure of the IDE/insulin complex. In this scenario, although the cleavage sites involved in the interaction of insulin with IDE are known, a convenient experimental method that is able to identify in a complete and unambiguous way, all the peptide fragments generated by such interaction has yet to be found. MS-based experiments have often represented to be invaluable tools for the assessment of the cleavage sites, but the reported MS-spectra always show a partial coverage of all the peptide fragments generated by the enzyme interaction, lacking a complete characterization. In this work, we report a new experimental procedure by which an unambiguous as well as complete assignment of all the peptide fragments generated by the interaction of insulin with IDE is described. Atmospheric pressure/matrix-assisted laser desorption ionization (AP/MALDI) mass spectra are reported and the data recorded, together with the introduction of a reduction/alkylation step, allows us to fully characterize the cleavage sites of the bovine insulin interacting with IDE. Different experimental conditions are screened and some insights into the IDE/insulin system regarding preference of the cleavage and its dependence on particular experimental conditions used are also given. Investigation on the tendency that different insulin fragments have toward aggregation is also carried out. Good reproducibility, global and unambiguous assignment, low time-consuming experimental procedure, and requirements of enzyme in small amounts are some of the advantages of the proposed AP/MALDI based approach.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18085545     DOI: 10.1002/jms.1348

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  10 in total

Review 1.  Molecular mass spectrometry imaging in biomedical and life science research.

Authors:  Jaroslav Pól; Martin Strohalm; Vladimír Havlíček; Michael Volný
Journal:  Histochem Cell Biol       Date:  2010-10-28       Impact factor: 4.304

2.  On-chip solid-phase extraction pre-concentration/focusing substrates coupled to atmospheric pressure matrix-assisted laser desorption/ionization ion trap mass spectrometry for high sensitivity biomolecule analysis.

Authors:  Arti Navare; Marcela Nouzova; Fernando G Noriega; Salvador Hernández-Martínez; Christoph Menzel; Facundo M Fernández
Journal:  Rapid Commun Mass Spectrom       Date:  2009-02       Impact factor: 2.419

3.  Enzyme solid-state support assays: a surface plasmon resonance and mass spectrometry coupled study of immobilized insulin degrading enzyme.

Authors:  Giuseppe Grasso; Ashley I Bush; Roberta D'Agata; Enrico Rizzarelli; Giuseppe Spoto
Journal:  Eur Biophys J       Date:  2008-12-02       Impact factor: 1.733

4.  Molecular basis of catalytic chamber-assisted unfolding and cleavage of human insulin by human insulin-degrading enzyme.

Authors:  Marika Manolopoulou; Qing Guo; Enrico Malito; Alexander B Schilling; Wei-Jen Tang
Journal:  J Biol Chem       Date:  2009-03-25       Impact factor: 5.157

5.  Structure, function, and regulation of insulin-degrading enzyme.

Authors:  Raymond E Hulse; Luis A Ralat; Tang Wei-Jen
Journal:  Vitam Horm       Date:  2009       Impact factor: 3.421

6.  Comparison of Vacuum MALDI and AP-MALDI Platforms for the Mass Spectrometry Imaging of Metabolites Involved in Salt Stress in Medicago truncatula.

Authors:  Caitlin Keller; Junko Maeda; Dhileepkumar Jayaraman; Sanhita Chakraborty; Michael R Sussman; Jeanne M Harris; Jean-Michel Ané; Lingjun Li
Journal:  Front Plant Sci       Date:  2018-08-28       Impact factor: 5.753

Review 7.  Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme.

Authors:  Carlos M González-Casimiro; Beatriz Merino; Elena Casanueva-Álvarez; Tamara Postigo-Casado; Patricia Cámara-Torres; Cristina M Fernández-Díaz; Malcolm A Leissring; Irene Cózar-Castellano; Germán Perdomo
Journal:  Biomedicines       Date:  2021-01-17

8.  Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug.

Authors:  Grazia Raffaella Tundo; Diego Sbardella; Francesco Oddone; Giuseppe Grasso; Stefano Marini; Maria Grazia Atzori; Anna Maria Santoro; Danilo Milardi; Francesco Bellia; Gabriele Macari; Grazia Graziani; Fabio Polticelli; Paolo Cascio; Mariacristina Parravano; Massimo Coletta
Journal:  Biomolecules       Date:  2022-02-16

9.  Neuroprotective Effect of Carnosine Is Mediated by Insulin-Degrading Enzyme.

Authors:  Alessia Distefano; Giuseppe Caruso; Valentina Oliveri; Francesco Bellia; Diego Sbardella; Gabriele Antonio Zingale; Filippo Caraci; Giuseppe Grasso
Journal:  ACS Chem Neurosci       Date:  2022-04-26       Impact factor: 5.780

10.  IDE Degrades Nociceptin/Orphanin FQ through an Insulin Regulated Mechanism.

Authors:  Gabriele Antonio Zingale; Francesco Bellia; Ikhlas Mohamed Mohamud Ahmed; Przemyslaw Mielczarek; Jerzy Silberring; Giuseppe Grasso
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.